MedTrace Logo

Mucosal Impedance in Pediatric Population

NCT02320981 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 127

Last updated 2017-05-01

No results posted yet for this study

Summary

Our hypothesis is that patients with GERD and/or Eosinophilic Esophagitis (EE) have lower esophageal impedance measurements when compared to patients who do not have GERD or EE.

Conditions

  • Gastroesophageal Reflux Disease (GERD)
  • Eosinophilic Esophagitis (EoE)
  • Functional Dyspepsia

Interventions

DIAGNOSTIC_TEST

Standard of Care esophagogastroduodenoscopy (EGD) with measurement of mucosal impedance

Sponsors & Collaborators

  • National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

    collaborator NIH

  • Vanderbilt University Medical Center

    lead OTHER

Principal Investigators

  • Mary Allyson Lowry, MD · Vanderbilt University Medical Center

  • Sari Acra, MD · Vanderbilt University Medical Center

  • Michael Vaezi, MD, PhD · Vanderbilt University Medical Center

Eligibility

Min Age
1 Year
Max Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2014-08-31
Primary Completion
2016-09-30
Completion
2016-09-30

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02320981 on ClinicalTrials.gov